Recent Tech Transfer Deals (03/1997)
This article was originally published in Start Up
Executive SummarySummarizing the month in tech transfer deals between Academia and Industry.
You may also be interested in...
Company says it has learnt from gene therapy flop Glybera, and claims best-in-class status for viral vector.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.